753P IN10018 in combination with pegylated liposomal doxorubicin (PLD) in platinum-resistant ovarian cancer (PROC): A single-arm, phase Ib clinical trial

L Wu,J Wang,L Wang,W Lu,K Wang,A Lin,N Li,L Li,N Su,S Xie,J Jiang

doi:10.1016/j.annonc.2023.09.1932

753P IN10018 in combination with pegylated liposomal doxorubicin (PLD) in platinum-resistant ovarian cancer (PROC): A single-arm, phase Ib clinical trial

L Wu, J Wang + Show 9 more

Open Access

https://doi.org/10.1016/j.annonc.2023.09.1932

Copy DOI

Journal: Annals of Oncology	Publication Date: Oct 1, 2023
Citations: 2

Affiliation: Chinese Academy of Medical Sciences & Peking Union Medical College, Hunan Cancer Hospital, Henan Cancer Hospital, Women's Hospital, School of Medicine, Zhejiang University, Tianjin Medical University Cancer Institute and Hospital, Kingmed Diagnostics

#Pegylated Liposomal Doxorubicin #Phase Ib Clinical Trial + Show 5 more

Abstract
Full-Text PDF
Similar Papers

Abstract

753P IN10018 in combination with pegylated liposomal doxorubicin (PLD) in platinum-resistant ovarian cancer (PROC): A single-arm, phase Ib clinical trial

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.